As of 2025-03-18, the Relative Valuation of Crinetics Pharmaceuticals Inc (CRNX) is (39.77) USD. This relative valuation is based on P/E multiples. With the latest stock price at 35.20 USD, the upside of Crinetics Pharmaceuticals Inc based on Relative Valuation is -213.0%.
The range of the Relative Valuation is (38.48) - (50.35) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 12.0x - 16.8x | 14.4x |
| Forward P/E multiples | 5.1x - 15.7x | 10.4x |
| Fair Price | (38.48) - (50.35) | (39.77) |
| Upside | -209.3% - -243.0% | -213.0% |
| Date | P/E |
| 2025-03-07 | -10.38 |
| 2025-03-06 | -10.64 |
| 2025-03-05 | -10.59 |
| 2025-03-04 | -10.62 |
| 2025-03-03 | -10.65 |
| 2025-02-28 | -11.16 |
| 2025-02-27 | -10.36 |
| 2025-02-26 | -10.15 |
| 2025-02-25 | -10.07 |
| 2025-02-24 | -10.80 |
| 2025-02-21 | -11.68 |
| 2025-02-20 | -11.49 |
| 2025-02-19 | -11.41 |
| 2025-02-18 | -11.08 |
| 2025-02-14 | -10.98 |
| 2025-02-13 | -10.99 |
| 2025-02-12 | -10.98 |
| 2025-02-11 | -10.89 |
| 2025-02-10 | -11.39 |
| 2025-02-07 | -11.53 |
| 2025-02-06 | -12.07 |
| 2025-02-05 | -12.25 |
| 2025-02-04 | -12.60 |
| 2025-02-03 | -12.10 |
| 2025-01-31 | -12.57 |
| 2025-01-30 | -12.55 |
| 2025-01-29 | -12.28 |
| 2025-01-28 | -11.92 |
| 2025-01-27 | -11.91 |
| 2025-01-24 | -12.10 |
| 2025-01-23 | -12.22 |
| 2025-01-22 | -12.05 |
| 2025-01-21 | -12.09 |
| 2025-01-17 | -11.65 |
| 2025-01-16 | -11.38 |
| 2025-01-15 | -11.45 |
| 2025-01-14 | -11.11 |
| 2025-01-13 | -12.15 |
| 2025-01-10 | -12.66 |
| 2025-01-08 | -15.12 |
| 2025-01-07 | -15.41 |
| 2025-01-06 | -15.74 |
| 2025-01-03 | -16.57 |
| 2025-01-02 | -16.07 |
| 2024-12-31 | -15.94 |
| 2024-12-30 | -15.80 |
| 2024-12-27 | -16.17 |
| 2024-12-26 | -16.81 |
| 2024-12-24 | -16.82 |
| 2024-12-23 | -16.83 |